10th Annual Symposium

GRIDS 2024

Epigenetics and Epigenomics in Lysosomal Disorders: Bridging Molecular Insights and Therapeutic Innovations

November 24–25, 2024 · Capital One Hall, 7750 Capital One Tower Road, Tysons, Virginia 22102

10th Annual GRIDS Symposium

The 10th Annual GRIDS Symposium convenes global experts to discuss epigenetics and epigenomics in lysosomal disorders, bridging molecular insights with therapeutic innovations. Through two days of keynote lectures, research presentations, and a clinical workshop, GRIDS 2024 fosters interdisciplinary collaboration that drives innovation and improves patient outcomes in lysosomal storage and rare genetic disorders.

Program highlights

  • Overview of Epigenetics and Epigenomics in Lysosomal Disorders
  • Epigenetic and Epigenomic Signatures in Lysosomal Disorder Pathology
  • Epigenetic Modifiers as Therapeutic Targets
  • Understanding the Global Differences in Lysosomal Disorders for Patient Care
  • Fabry Clinical Workshop (by invitation only)

Speakers

Keynote presentation

David G. WarnockMD

Professor Emeritus of Medicine, University of Alabama at Birmingham, Alabama, USA

Young Investigator Awards

  • David Smerkous

    PhD Candidate in Artificial Intelligence, Oregon State University, Oregon, USA

  • Majdolen (Joleen) IstaitiBSc, MBA

    Clinical Study Coordinator, Gaucher Unit, Shaare Zedek Medical Center, Jerusalem, Israel

Agenda Overview

Day 1

November 24, 2024
  1. IOverview of Epigenetics and Epigenomics in Lysosomal Disorders
  2. IIEpigenetic and Epigenomic Signatures in Lysosomal Disorder Pathology
  3. IIIEpigenetic Modifiers as Therapeutic Targets

Day 2

November 25, 2024
  1. IVUnderstanding the Global Differences in Lysosomal Disorders for Patient Care

Sponsors

This program is supported by educational grants from the following companies.

Enduring CMEs